IL-4 receptor α polymorphisms are predictors of a pharmacogenetic response to a novel IL-4/IL-13 antagonist

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 126; no. 4; pp. 875 - 878
Main Authors Slager, Rebecca E., PhD, Hawkins, Gregory A., PhD, Ampleford, Elizabeth J., PhD, Bowden, Alexandra, BS, Stevens, Lauren E., BS, Morton, Matthew T., BS, Tomkinson, Adrian, PhD, Wenzel, Sally E., MD, Longphre, Malinda, PhD, Bleecker, Eugene R., MD, Meyers, Deborah A., PhD
Format Journal Article
LanguageEnglish
Published United States Mosby, Inc 01.10.2010
Subjects
Allergy and Immunology
Animals
Anti-Asthmatic Agents - administration & dosage
Asthma - drug therapy
Asthma - genetics
Drug Evaluation, Preclinical - veterinary
Humans
Interleukin-13 - antagonists & inhibitors
Interleukin-4 - analogs & derivatives
Interleukin-4 - antagonists & inhibitors
Interleukin-4 Receptor alpha Subunit - genetics
Macaca fascicularis
Pharmacogenetics
Polymorphism, Single Nucleotide
Predictive Value of Tests
Treatment Outcome
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Feature-2
ObjectType-Correspondence-1
content type line 66
ObjectType-News-4
ObjectType-Article-3
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2010.08.001